Mission Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $906K | Buy |
4,139
+95
| +2% | +$20.8K | 0.02% | 332 |
|
|
2025
Q1 | $905K | Sell |
4,044
-141
| -3% | -$31.6K | 0.02% | 310 |
|
|
2024
Q4 | $1.37M | Sell |
4,185
-64
| -2% | -$21K | 0.03% | 220 |
|
|
2024
Q3 | $1.28M | Sell |
4,249
-587
| -12% | -$176K | 0.03% | 231 |
|
|
2024
Q2 | $1.59M | Buy |
4,836
+463
| +11% | +$153K | 0.04% | 186 |
|
|
2024
Q1 | $1.73M | Sell |
4,373
-158
| -3% | -$62.5K | 0.05% | 193 |
|
|
2023
Q4 | $1.6M | Buy |
4,531
+114
| +3% | +$40.1K | 0.05% | 170 |
|
|
2023
Q3 | $1.66M | Buy |
4,417
+25
| +0.6% | +$9.38K | 0.06% | 144 |
|
|
2023
Q2 | $1.68M | Sell |
4,392
-40
| -0.9% | -$15.3K | 0.06% | 145 |
|
|
2023
Q1 | $1.54M | Buy |
4,432
+233
| +6% | +$80.7K | 0.06% | 155 |
|
|
2022
Q4 | $988K | Buy |
4,199
+237
| +6% | +$55.8K | 0.05% | 196 |
|
|
2022
Q3 | $975K | Buy |
3,962
+108
| +3% | +$26.6K | 0.05% | 182 |
|
|
2022
Q2 | $1.17M | Buy |
3,854
+714
| +23% | +$216K | 0.06% | 165 |
|
|
2022
Q1 | $1.29M | Buy |
3,140
+308
| +11% | +$126K | 0.06% | 154 |
|
|
2021
Q4 | $1.33M | Sell |
2,832
-52
| -2% | -$24.4K | 0.06% | 148 |
|
|
2021
Q3 | $1.22M | Sell |
2,884
-268
| -9% | -$114K | 0.06% | 148 |
|
|
2021
Q2 | $1.13M | Sell |
3,152
-43
| -1% | -$15.4K | 0.06% | 155 |
|
|
2021
Q1 | $900K | Buy |
3,195
+291
| +10% | +$82K | 0.05% | 160 |
|
|
2020
Q4 | $823K | Buy |
2,904
+461
| +19% | +$131K | 0.05% | 158 |
|
|
2020
Q3 | $672K | Sell |
2,443
-146
| -6% | -$40.2K | 0.05% | 163 |
|
|
2020
Q2 | $588K | Buy |
2,589
+69
| +3% | +$15.7K | 0.05% | 163 |
|
|
2020
Q1 | $384K | Sell |
2,520
-57
| -2% | -$8.69K | 0.04% | 184 |
|
|
2019
Q4 | $387K | Buy |
2,577
+39
| +2% | +$5.86K | 0.04% | 209 |
|
|
2019
Q3 | $360K | Sell |
2,538
-130
| -5% | -$18.4K | 0.04% | 202 |
|
|
2019
Q2 | $334K | Buy |
2,668
+62
| +2% | +$7.76K | 0.04% | 223 |
|
|
2019
Q1 | $287K | Buy |
2,606
+226
| +9% | +$24.9K | 0.03% | 232 |
|
|
2018
Q4 | $233K | Buy |
+2,380
| New | +$233K | 0.03% | 232 |
|